
From uncovering new benefits of semaglutide to targeting hypercortisolism in people with type 2 diabetes, here are 5 key updates from the annual meeting.
Professor of Medicine, University of Toronto, and Head of the Diabetes and Endocrine in Pregnancy Program at Mount Sinai Hospital, to learn more about how T1D care for pregnant women continues to evolve. Feig also serves as an Adjunct Scientist at the Institute for Clinical and Evaluative Sciences, is a Member of the Motherisk Team at SickKids Hospital, and was Past Chair of the Diabetes in Pregnancy Interest Group for the ADA

From uncovering new benefits of semaglutide to targeting hypercortisolism in people with type 2 diabetes, here are 5 key updates from the annual meeting.

Donovan and Feig shared exciting findings and further research from a study evaluating an insulin pump with Control-IQ technology with Dexcom G6 sensor.

Automated insulin delivery systems enhance blood glucose control for pregnant women with type 1 diabetes, potentially advancing diabetes care.